{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:10:45Z","timestamp":1780391445954,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41374-021-00711-5","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T10:02:28Z","timestamp":1638612148000},"page":"422-431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Inhibition of TXNDC5 attenuates lipopolysaccharide-induced septic shock by altering inflammatory responses"],"prefix":"10.1016","volume":"102","author":[{"given":"Yanping","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41374-021-00711-5_bib1","first-page":"260","article-title":"Definitions and pathophysiology of sepsis","volume":"43","author":"Sagy","year":"2013","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"key":"10.1038\/s41374-021-00711-5_bib2","first-page":"199","article-title":"Methylene blue? Therapeutic alternative in the management of septic shock refractory to norepinephrine","volume":"16","author":"Arag\u00f3n-Bened\u00ed","year":"2020","journal-title":"Signa. Vitae"},{"key":"10.1038\/s41374-021-00711-5_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/imr.12499","article-title":"The immune system's role in sepsis progression, resolution, and long-term outcome","volume":"274","author":"Delano","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1038\/s41374-021-00711-5_bib4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1586\/14787210.2013.829633","article-title":"What is sepsis? What is severe sepsis? What is septic shock? Searching for objective definitions among the winds of doctrines and wild theories","volume":"11","author":"Gaieski","year":"2013","journal-title":"Expert. Rev. Anti. Infect. Ther."},{"key":"10.1038\/s41374-021-00711-5_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4161\/viru.26482","article-title":"Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock","volume":"5","author":"De Backer","year":"2014","journal-title":"Virulence"},{"key":"10.1038\/s41374-021-00711-5_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/viru.27372","article-title":"Epidemiology of severe sepsis","volume":"5","author":"Mayr","year":"2014","journal-title":"Virulence"},{"key":"10.1038\/s41374-021-00711-5_bib7","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.3389\/fimmu.2018.02632","article-title":"Park 7: a novel therapeutic target for macrophages in sepsis-induced immunosuppression","volume":"9","author":"Cheng","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1038\/s41374-021-00711-5_bib8","doi-asserted-by":"crossref","unstructured":"Dickson, K. & Lehmann, C. Inflammatory response to different toxins in experimental sepsis models. Int. J. Mol. Sci.20, 4341 (2019).","DOI":"10.3390\/ijms20184341"},{"key":"10.1038\/s41374-021-00711-5_bib9","doi-asserted-by":"crossref","unstructured":"Kany, S., Vollrath, J. T., & Relja B. Cytokines in inflammatory disease. Int. J. Mol. Sci.20, 6008 (2019).","DOI":"10.3390\/ijms20236008"},{"key":"10.1038\/s41374-021-00711-5_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","article-title":"Cytokine storm and sepsis disease pathogenesis","volume":"39","author":"Chousterman","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1038\/s41374-021-00711-5_bib11","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","article-title":"Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and m2(LPS-) vs. alternatively activated macrophages","volume":"10","author":"Orecchioni","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1038\/s41374-021-00711-5_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.semcancer.2006.09.003","article-title":"Thioredoxin and protein kinases in redox signaling","volume":"16","author":"Fujino","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"10.1038\/s41374-021-00711-5_bib13","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1161\/CIRCRESAHA.117.312130","article-title":"Endoplasmic reticulum protein TXNDC5 augments myocardial fibrosis by facilitating extracellular matrix protein folding and redox-sensitive cardiac fibroblast activation","volume":"122","author":"Shih","year":"2018","journal-title":"Circ. Res."},{"key":"10.1038\/s41374-021-00711-5_bib14","doi-asserted-by":"crossref","first-page":"23501","DOI":"10.3390\/ijms151223501","article-title":"TXNDC5, a newly discovered disulfide isomerase with a key role in cell physiology and pathology","volume":"15","author":"Horna-Terr\u00f3n","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1038\/s41374-021-00711-5_bib15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.gendis.2018.09.003","article-title":"A critical role of the thioredoxin domain containing protein 5 (TXNDC5) in redox homeostasis and cancer development","volume":"5","author":"Chawsheen","year":"2018","journal-title":"Genes Dis."},{"key":"10.1038\/s41374-021-00711-5_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/cmi.2017.20","article-title":"TXNDC5 synergizes with HSC70 to exacerbate the inflammatory phenotype of synovial fibroblasts in rheumatoid arthritis through NF-\u03baB signaling","volume":"15","author":"Wang","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1038\/s41374-021-00711-5_bib17","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association.","year":"2013","journal-title":"JAMA"},{"key":"10.1038\/s41374-021-00711-5_bib18","unstructured":"National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals. The National Academies Collection: Reports Funded by National Institutes of Health. Guide for the Care and Use of Laboratory Animals. (National Academies Press (US), National Academy of Sciences; Washington (DC), 2011)."},{"key":"10.1038\/s41374-021-00711-5_bib19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/1753425920966380","article-title":"Identification of key genes and novel immune infiltration-associated biomarkers of sepsis","volume":"26","author":"Xu","year":"2020","journal-title":"Innate. Immun."},{"key":"10.1038\/s41374-021-00711-5_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1038\/s41374-021-00711-5_bib21","doi-asserted-by":"crossref","first-page":"3.20.21","DOI":"10.1002\/0471142735.im0320s110","article-title":"Isolation of mouse neutrophils","volume":"110","author":"Swamydas","year":"2015","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1038\/s41374-021-00711-5_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1753425913516524","article-title":"TAT-SNAP-23 treatment inhibits the priming of neutrophil functions contributing to shock and\/or sepsis-induced extra-pulmonary acute lung injury","volume":"21","author":"Bai","year":"2015","journal-title":"Innate. Immun."},{"key":"10.1038\/s41374-021-00711-5_bib23","doi-asserted-by":"crossref","first-page":"105899","DOI":"10.1016\/j.intimp.2019.105899","article-title":"Novel pharmacological inhibition of EZH2 attenuates septic shock by altering innate inflammatory responses to sepsis","volume":"76","author":"Zhang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1038\/s41374-021-00711-5_bib24","doi-asserted-by":"crossref","unstructured":"Wang, J., et al. iNOS interacts with autophagy receptor p62 and is degraded by autophagy in macrophages. Cells8, 1255 (2019).","DOI":"10.3390\/cells8101255"},{"key":"10.1038\/s41374-021-00711-5_bib25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med."},{"key":"10.1038\/s41374-021-00711-5_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1038\/s41374-021-00711-5_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/1479-7364-6-6","article-title":"The human protein disulfide isomerase gene family","volume":"6","author":"Galligan","year":"2012","journal-title":"Hum. Genomics"},{"key":"10.1038\/s41374-021-00711-5_bib28","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar3429","article-title":"Investigating a pathogenic role for TXNDC5 in rheumatoid arthritis","volume":"13","author":"Chang","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1038\/s41374-021-00711-5_bib29","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.3892\/ijo.2013.2123","article-title":"Investigating a pathogenic role for TXNDC5 in tumors","volume":"43","author":"Chang","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1038\/s41374-021-00711-5_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ccc.2017.08.003","article-title":"Mechanisms of organ dysfunction in sepsis","volume":"34","author":"Pool","year":"2018","journal-title":"Crit. Care Clin."},{"key":"10.1038\/s41374-021-00711-5_bib31","first-page":"629","article-title":"Organ dysfunction in sepsis: an ominous trajectory from infection to death","volume":"92","author":"Caraballo","year":"2019","journal-title":"Yale J. Biol. Med."},{"key":"10.1038\/s41374-021-00711-5_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1615\/CritRevImmunol.2015015461","article-title":"Pathogenesis of multiple organ failure in sepsis","volume":"35","author":"Rossaint","year":"2015","journal-title":"Crit. Rev. Immunol."},{"key":"10.1038\/s41374-021-00711-5_bib33","first-page":"669","article-title":"Role of cytokines as a double-edged sword in sepsis","volume":"27","author":"Chaudhry","year":"2013","journal-title":"In Vivo"},{"key":"10.1038\/s41374-021-00711-5_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-2015-1","article-title":"Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis","volume":"10","author":"Cao","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1038\/s41374-021-00711-5_bib35","doi-asserted-by":"crossref","first-page":"165974","DOI":"10.1155\/2013\/165974","article-title":"Cytokines in sepsis: potent immunoregulators and potential therapeutic targets\u2013an updated view","volume":"2013","author":"Schulte","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1038\/s41374-021-00711-5_bib36","doi-asserted-by":"crossref","unstructured":"Su, Y., Gao, J., Kaur, P., & Wang, Z. Neutrophils and macrophages as targets for development of nanotherapeutics in inflammatory diseases. Pharmaceutics12, 1222 (2020).","DOI":"10.3390\/pharmaceutics12121222"},{"key":"10.1038\/s41374-021-00711-5_bib37","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bbrc.2015.07.008","article-title":"Intranuclear interactomic inhibition of NF-\u03baB suppresses LPS-induced severe sepsis","volume":"464","author":"Park","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1038\/s41374-021-00711-5_bib38","article-title":"Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGF\u03b2 signaling through TGFBR1 stabilization","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41374-021-00711-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41374-021-00711-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722000551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722000551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41374-021-00711-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:23:59Z","timestamp":1758396239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722000551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0023683722000551"],"URL":"https:\/\/doi.org\/10.1038\/s41374-021-00711-5","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of TXNDC5 attenuates lipopolysaccharide-induced septic shock by altering inflammatory responses","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41374-021-00711-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}